Please login to the form below
Lovenox
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lovenox was produced by Sanofi.
HIV prevention pill heads July CHMP recommendations
Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -
Heart drug sales continue downward spiral
Sanofi has a number of CV medicines including Aprovel (irbesartan), Lovenox (enoxaparin) and the co-marketed Plavix (clopidogrel), which collectively made the firm 4.2bn euro ($4.7bn) last year, helping
European licence for BMS/Pfizer's Eliquis in DVT and PE
safety endpoint of major bleeding versus warfarin and enoxaparin - the active ingredient in Sanofi's out-of-patent anticoagulant Lovenox. .
Sanofi returns to growth in Q3
Lovenox (enoxaparin) and Aprovel/Avapro (irbesartan) for high blood pressure continued to slide.
Sanofi cuts forecasts but says worst effects of patent cliff have passed
drugs such as blood thinners Lovenox (enoxaparin) and Plavix (clopidogrel) recedes and growth platforms - including diabetes, vaccines and speciality medicine subsidiary Genzyme - gain the ascendancy.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Novartis’ MS therapy Mayzent approved by NICE
- FDA sets November date for expert panel review of Biogen’s aducanumab
- UK scientists begin testing BCG vaccine for severe COVID-19 protection
- Eli Lilly’s COVID-19 antibody trial paused due to safety issue
- How will the events and exhibitions industry change post-Coronavirus?
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Every superhero has an origin story – what’s yours?
- Live Webinar: Solving the Caregiver Crisis Through Technology
- "Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
- Embracing the QR code: a health and humanity perspective
- Lilly buys biotech firm Disarm Therapeutics for $135m
- Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- "Fishbowl" Web Meeting for Internal POA Discussions: a Customer Story
- Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting....
- Whats the difference between patient engagement and patient experience?
- We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same....
- Building trust in clinical trials whilst it is in the public eye
- We’re all well aware that healthcare organisations are generally perceived to be untrustworthy. According to Edelman’s 2018 Trust Barometer, we even saw a clear global decline of public trust in...
Quick links
Infographics
